The landscape of dementia diagnosis has advanced considerably with the advent of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent checks that will detect Alzheimer's pathology yrs before signs arise. Though these technological advances symbolize extraordinary development in comprehending neurodegenerative conditions,